
|
Eighty-two percent of adults in the United States take at least one medication, including prescription and nonprescription drugs and vitamins and supplements. The scientific mission of the Vanderbilt Division of Clinical Pharmacology is to understand mechanisms of drug action in humans in order to improve therapeutics. Research in the Division bridges basic pharmacology and the clinical sciences. Founded in 1963, the Vanderbilt Division of Clinical Pharmacology is one of the oldest and largest in the world. The Division is unique in that it resides in both a clinical department, Internal Medicine, and a basic science department, Pharmacology. Consequently, its investigators are uniquely poised to make significant advances in both basic and translational research. Clinical Pharmacology at Vanderbilt is going strong. With over 32 faculty and 27 postdoctoral fellows, members of the division are engaged in a wide variety of research efforts. The division integrates with other efforts in the pharmacological sciences at Vanderbilt including the Oates Institute of Experimental Therapeutics, the Department of Pharmacology, the Vanderbilt Institute for Chemical Biology, and the Center in Molecular Toxicology.
Main areas of research interest within the division include:
Pharmacogenetics and drug disposition and metabolism.Fatty acid oxidation and lipid mediator pharmacology.Ion channel pharmacology and arrhythmia pharmacogenomics.Human cardiovascular pharmacology and autonomic dysfunction.Bone and cancer pharmacology. Pharmacoepidemiology.
We invite you to explore our website and the Division in order to discover the opportunities available for research in Clinical Pharmacology at Vanderbilt.
Nancy J. Brown, M.D. Chief, Division of Clinical Pharmacology
|
|
|